Clinical study explores regenerative therapy for epilepsy

Mayo Clinic is participating in the first in-human investigation of regenerative therapy for the treatment of drug-resistant epilepsy. The multicenter study will test the safety of implanting interneurons into the hippocampus in patients with the disease. Future studies are planned to investigate the potential for these cells to restore normal excitatory-inhibitory balance.Continue reading

Applications open for XLR8 Health Tech Program

XLR8 PBC is an 8-day intensive program for scale-ready (series A/B) companies seeking the capital, experience, and industry validation to move to the next level. The program emphasizes finding the right capital at the right time, growth-stage executive matchmaking, and corporate partnerships to validate market fit. With resources like access to innovative collision spaces, student analysts, and a robust ecosystem, XLR8 is dedicated to enhancing the growth potential of scale-ups.Continue reading